Management of mitral stenosis using 2D and 3D echo-Doppler imaging

Area of Science:

• Cardiology
• Medical Imaging
• Echocardiography

Background:

• Rheumatic fever, a cause of mitral stenosis (MS), persists globally, leading to significant morbidity and mortality.
• Untreated mitral stenosis causes substantial health burdens, particularly in non-industrialized regions.
• Echocardiography is the primary diagnostic tool for evaluating mitral valve obstruction and MS severity.

Purpose of the Study:

• To detail the role of echocardiography in assessing mitral stenosis severity and morphology.
• To outline current guidelines for grading MS using valve areas, gradients, and pulmonary pressures.
• To discuss the indications for transthoracic and transesophageal echocardiography in MS evaluation.

Main Methods:

• Transthoracic echocardiography (TTE) for routine MS severity grading and valve morphology assessment.
• Transesophageal echocardiography (TEE) for difficult TTE assessments and thrombus exclusion.
• Three-dimensional echocardiography (3D TTE/TEE) for enhanced physiological and morphological insights.

Main Results:

• Echocardiographic parameters like valve area, mean Doppler gradients, and pulmonary pressures are key for MS severity assessment.
• TTE is generally sufficient, while TEE is reserved for specific clinical scenarios.
• 3D echocardiography offers superior detail in characterizing valve anatomy and function.

Conclusions:

• Accurate echocardiographic assessment is vital for managing mitral stenosis.
• Treatment decisions, including percutaneous mitral balloon valvuloplasty (PMBV) or surgery, depend on MS etiology and valve morphology.
• Specific anatomical features predict the success of PMBV, while others may contraindicate the procedure.